£1.55m
+2%vs Dec 2024Active13761050Private limited companyManchester
IMPERAGEN LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Imperagen Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Imperagen Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
IMPERAGEN LIMITED is an active private limited company (company number 13761050) incorporated on 23 November 2021, registered in Manchester. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £1.55m and cash of £975k, with 14 employees on average. Net assets rose 2% on the prior period (£1.52m). Across the last 3 periods on record the net-asset trend is volatile.
Peer position · net assets
By net assets it sits in the top quarter of 138 comparable companies in Manchester (median £436, upper quartile £124k).
02
Ownership and control
No active person with significant control is registered.
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 23 November 20214 yrs ago
- Next accounts due
- 30 September 2027in 338 days
- Confirmation statement due
- 7 December 2026in 41 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£975k
+63%vs Dec 2024Not reported
14
+17%vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £1.55m | £975k | £128k | — | — | — | 14 |
| 31 December 2024 | £1.52m | £599k | £230k | — | — | — | 12 |
| 31 December 2023 | £2.45m | £1.60m | £80k | — | — | — | 9 |
Cash per employee£70kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £1,547,297 at 31 December 2025
- Cash at bank of £50,000 or moreCash £975,406
- Three or more accounting periods on record3 periods on record
- Incorporated two to five years agoIncorporated 23 November 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 338 days
- Confirmation statement duein 41 days
- Accounts period endNet assets £1.55m · small accounts
- Accounts period endNet assets £1.52m · small accounts
- Accounts period endNet assets £2.45m · small accounts
- Incorporated
08
Similar companies in Manchester
- ADISO THERAPEUTICS LIMITEDAltrincham · inc. Nov 2021
- OAK HILL BIO HOLDINGS LTDAltrincham · inc. Nov 2021
- DECENT RESEARCH LTDMacclesfield · inc. Oct 2021
- CARDIOLOGY DEVICES LTDWarrington · inc. Oct 2021
- OHB NEONATOLOGY LTDAltrincham · inc. Jan 2022
- OHB DME LTDAltrincham · inc. Jan 2022
All companies incorporated on 23 November 2021 · in Nov 2021.
09
Reminders for IMPERAGEN LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.